Hemispherx BioPharma, Inc (NYSEAMEX:HEB) Long Term Investor Alert: Investigation
An investigation on behalf of current long term investors in Hemispherx BioPharma, Inc (NYSE:HEB) shares over possible breaches of fiduciary duty by certain officers and directors was announced and NYSE:HEB stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com
View full press release